> ## Content Index
> Fetch the complete content index at: https://morpheus-research-labs.ghost.io/llms.txt
> Use this file to discover other available public pages before exploring further.

# Kisspeptin Research: From Metastasis Suppressor Gene to Gatekeeper of the Reproductive Axis
- URL: https://morpheus-research-labs.ghost.io/kisspeptin-research/
- Published: 2026-11-12T15:14:50.000Z
- Updated: 2026-11-12T15:14:50.000Z
- Description: What the published literature reports on kisspeptin: the KISS1 gene, the 2001 receptor deorphanization, GPR54 genetics, GnRH release, KNDy neurons and desensitisation.
- Author: Morpheus Research
- Tags: Kisspeptin, Neuroendocrinology, Peptide Research

Few peptide stories turned around as sharply as kisspeptin's. The gene was found in a cancer lab in 1996, its receptor was identified in 2001, and by 2003 two genetics papers had placed it at the top of the hormonal cascade that controls puberty and fertility. This overview walks through what the published papers report: the gene and its peptide fragments, the receptor, the genetic findings, the animal pharmacology, and the open questions. It is written for researchers and is not a guide to any use in people.

## A gene named after a chocolate town

In 1996, Lee, Miele, Hicks and colleagues at Penn State's Hershey campus reported in the *Journal of the National Cancer Institute* a new gene whose expression suppressed metastasis of human melanoma cells without stopping their growth. They called it KiSS-1, a nod to the town's famous chocolate kisses, with "SS" standing for suppressor sequence. Lee and Welch followed up in 1997 in the *International Journal of Cancer* with work on genes expressed in metastasis-suppressed melanoma hybrid cells.

For five years, KiSS-1 was a cancer gene with no known partner.

## 2001: three groups find the receptor

In 2001, three groups independently matched KiSS-1-derived peptides to an orphan G protein-coupled receptor:

- **Ohtaki and colleagues** (*Nature*) purified a 54-residue C-terminally amidated peptide from human placenta, named it metastin, and showed it activated the orphan receptor hOT7T175\. Metastin inhibited chemotaxis and invasion of receptor-expressing CHO cells and attenuated pulmonary metastasis of receptor-transfected B16-BL6 melanoma cells in mice.
- **Kotani and colleagues** (*Journal of Biological Chemistry*) identified the peptides as the natural ligands of GPR54 and coined the name kisspeptins, isolating kisspeptin-54 along with shorter forms, kisspeptin-14 and kisspeptin-13, from placenta.
- **Muir and colleagues** (*Journal of Biological Chemistry*) reported the same receptor as AXOR12 and found high expression in placenta.

The receptor is now usually called KISS1R (formerly GPR54). All the active forms share the same C-terminal sequence ending in an Arg-Phe-amide, placing kisspeptins in the RF-amide peptide family. The shortest fully active fragment, kisspeptin-10 (human sequence YNWNSFGLRF-NH2, corresponding to metastin 45-54), is the form most often used in experimental pharmacology.

## 2003: the genetics that changed the field

The turn toward reproduction came from patients with hypogonadotropic hypogonadism, a condition in which puberty fails because the pituitary does not get the right hypothalamic signal.

In September 2003, de Roux and colleagues reported in *PNAS* a consanguineous family in which loss-of-function mutations in GPR54 segregated with hypogonadotropic hypogonadism. A month later, Seminara and colleagues published "The GPR54 gene as a regulator of puberty" in the *New England Journal of Medicine*, describing GPR54 mutations in affected people and Gpr54-deficient mice with the same failure of sexual maturation. One patient studied in detail had attenuated secretion of endogenous GnRH, and Messager and colleagues later reported that GnRH neurons in Gpr54-deficient mice look anatomically normal and project to the median eminence. Together these pointed to a problem with GnRH release rather than with how GnRH neurons develop.

The ligand side was confirmed nearly a decade later. Topaloglu and colleagues reported in the *New England Journal of Medicine* in 2012 an inactivating mutation in KISS1 itself in a large consanguineous family, resulting in failure of pubertal progression.

## What the animal pharmacology reports

The genetics prompted a wave of experiments asking whether kisspeptin acts on the GnRH system directly.

- **Mouse:** Gottsch and colleagues reported in *Endocrinology* in 2004 that both kisspeptin-54 and kisspeptin-10, given into the lateral cerebral ventricle, stimulated LH secretion in mice, that kisspeptin-54 stimulated FSH as well, and that the effect was blocked by pretreatment with the GnRH antagonist acyline. They also mapped KiSS-1 mRNA to hypothalamic areas involved in gonadotropin control, including the anteroventral periventricular nucleus and the arcuate nucleus. Messager and colleagues reported in *PNAS* in 2005 that GPR54 transcripts colocalise with GnRH neurons, that kisspeptin which stimulated LH and FSH release in wild-type mice had no effect in Gpr54-deficient mice, and, in sheep, that central kisspeptin produced a large release of GnRH into cerebrospinal fluid alongside a rise in LH.
- **Rat:** Navarro and colleagues characterised a potent LH-releasing activity of KiSS-1 peptide in rats (*Endocrinology*, 2005) and, in a companion paper, its effects on FSH. Castellano and colleagues reported that short-term fasting lowered hypothalamic KiSS-1 mRNA in prepubertal rats, and that chronic kisspeptin restored markers of pubertal activation in an undernutrition model, linking the system to body energy status.
- **Primate:** Shahab and colleagues reported in *PNAS* in 2005 that kisspeptin-10 elicited a robust GnRH discharge, read out as LH secretion, in agonadal juvenile male rhesus monkeys, and that a GnRH-receptor antagonist abolished it. Hypothalamic KiSS-1 mRNA rose with puberty in both sexes, and GPR54 mRNA rose about three-fold from the juvenile to midpubertal stage in intact females. The authors proposed increased GPR54 signalling as a contributor to the pubertal resurgence of pulsatile GnRH release.

## Pulses, desensitisation and KNDy neurons

The GnRH system works in pulses, and continuous exposure to GnRH itself shuts the pituitary down. Kisspeptin turned out to have a similar property at its own receptor. Seminara and colleagues reported in *Endocrinology* in 2006 that a continuous infusion of human metastin 45-54 in juvenile male rhesus monkeys desensitised GPR54-induced GnRH release, monitored indirectly through LH. Ramaswamy and colleagues extended this work in 2007, examining the effects of continuous intravenous metastin 45-54 on the hypothalamic-pituitary-testicular axis in adult male rhesus monkeys. For anyone designing experiments, this means that the timing and pattern of exposure, not only the concentration, shape the readout.

The cells producing the pulse were mapped over the following years. In the arcuate nucleus, kisspeptin is co-expressed with neurokinin B and dynorphin, and these cells were named KNDy neurons. Lehman, Coolen and Goodman's 2010 minireview in *Endocrinology* set out the model of KNDy cells as a central node in the control of GnRH pulses, in which neurokinin B is thought to act as a stimulatory signal and dynorphin as an inhibitory one within the network. Navarro and colleagues tested parts of this model in mice in a 2009 *Journal of Neuroscience* paper on how kisspeptin/dynorphin/neurokinin B neurons regulate GnRH secretion.

## Open questions

The literature still leaves several questions unsettled:

- **Cancer biology.** The original metastasis-suppressor finding has been followed by mixed results across tumour types, and how the anti-metastatic and reproductive functions relate is still being studied.
- **Peripheral roles.** Kisspeptin is abundant in placenta, and roles in placentation and outside the hypothalamus are less well defined than the central role.
- **Species differences.** Rodent, sheep and primate studies agree on the core role but differ in where kisspeptin neurons sit and how sex steroids feed back on them.

## Handling notes for the lab

Kisspeptin-10 is a short, C-terminally amidated decapeptide containing tryptophan, so the general rules for amidated, Trp-containing peptides apply: store lyophilised material cold and dry, limit freeze-thaw cycles, and protect solutions from light and oxidants. When comparing results between papers, check which fragment was used (kisspeptin-10, -14 or -54), because the longer forms differ in their pharmacokinetics and in vivo potency. Confirm identity by mass spectrometry and purity by HPLC on the certificate of analysis for each lot.

## Frequently asked questions

**Is kisspeptin the same as metastin?** Metastin is the name Ohtaki and colleagues gave the 54-residue peptide in 2001; it is the same molecule as kisspeptin-54.

**What is the difference between GPR54 and KISS1R?** They are two names for the same receptor. GPR54 was the orphan receptor's original name; KISS1R is the current gene nomenclature.

**Why is kisspeptin-10 used so often?** It is the shortest fragment that keeps full receptor activity, which makes it the simplest form to synthesise and study.

## Related reading

- [GHRP-6 Research: The Hexapeptide That Led to the Ghrelin Receptor](https://morpheus-research-labs.ghost.io/ghrp-6-peptide-research/)
- [Receptor Binding Assays Explained](https://morpheus-research-labs.ghost.io/receptor-binding-assays-explained/)
- [Peptide Degradation Pathways](https://morpheus-research-labs.ghost.io/peptide-degradation-pathways/)

## References

- Lee JH, Miele ME, Hicks DJ, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. *Journal of the National Cancer Institute.* 1996;88(23):1731-1737\. doi:10.1093/jnci/88.23.1731.
- Lee JH, Welch DR. Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. *International Journal of Cancer.* 1997;71(6):1035-1044\. PMID: 9185708.
- Ohtaki T, Shintani Y, Honda S, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. *Nature.* 2001;411(6837):613-617\. PMID: 11385580\. doi:10.1038/35079135.
- Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54\. *Journal of Biological Chemistry.* 2001;276(37):34631-34636\. PMID: 11457843\. doi:10.1074/jbc.M104847200.
- Muir AI, Chamberlain L, Elshourbagy NA, et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1\. *Journal of Biological Chemistry.* 2001;276(31):28969-28975\. PMID: 11387329\. doi:10.1074/jbc.M102743200.
- de Roux N, Genin E, Carel JC, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54\. *PNAS.* 2003;100(19):10972-10976\. PMID: 12944565\. doi:10.1073/pnas.1834399100.
- Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. *New England Journal of Medicine.* 2003;349(17):1614-1627\. PMID: 14573733\. doi:10.1056/NEJMoa035322.
- Gottsch ML, Cunningham MJ, Smith JT, et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. *Endocrinology.* 2004;145(9):4073-4077\. PMID: 15217982\. doi:10.1210/en.2004-0431.
- Messager S, Chatzidaki EE, Ma D, et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54\. *PNAS.* 2005;102(5):1761-1766\. PMID: 15665093\. doi:10.1073/pnas.0409330102.
- Navarro VM, Castellano JM, Fernández-Fernández R, et al. Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54\. *Endocrinology.* 2005;146(1):156-163\. PMID: 15375028\. doi:10.1210/en.2004-0836.
- Navarro VM, Castellano JM, Fernández-Fernández R, et al. Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat. *Endocrinology.* 2005;146(4):1689-1697\. PMID: 15637288\. doi:10.1210/en.2004-1353.
- Castellano JM, Navarro VM, Fernández-Fernández R, et al. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. *Endocrinology.* 2005;146(9):3917-3925\. PMID: 15932928\. doi:10.1210/en.2005-0337.
- Shahab M, Mastronardi C, Seminara SB, et al. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. *PNAS.* 2005;102(6):2129-2134\. PMID: 15684075\. doi:10.1073/pnas.0409822102.
- Seminara SB, Dipietro MJ, Ramaswamy S, et al. Continuous human metastin 45-54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (*Macaca mulatta*): a finding with therapeutic implications. *Endocrinology.* 2006;147(5):2122-2126\. PMID: 16469799\. doi:10.1210/en.2005-1550.
- Ramaswamy S, Seminara SB, Pohl CR, et al. Effect of continuous intravenous administration of human metastin 45-54 on the neuroendocrine activity of the hypothalamic-pituitary-testicular axis in the adult male rhesus monkey (*Macaca mulatta*). *Endocrinology.* 2007;148(7):3364-3370\. PMID: 17412800\. doi:10.1210/en.2007-0207.
- Navarro VM, Gottsch ML, Chavkin C, et al. Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B neurons in the arcuate nucleus of the mouse. *Journal of Neuroscience.* 2009;29(38):11859-11866\. PMID: 19776272\. doi:10.1523/JNEUROSCI.1569-09.2009.
- Lehman MN, Coolen LM, Goodman RL. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. *Endocrinology.* 2010;151(8):3479-3489\. PMID: 20501670\. doi:10.1210/en.2010-0022.
- Topaloglu AK, Tello JA, Kotan LD, et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. *New England Journal of Medicine.* 2012;366(7):629-635\. PMID: 22335740\. doi:10.1056/NEJMoa1111184.

---

*Research use only. All products sold by Morpheus Research are intended strictly for laboratory research and are not for human or veterinary consumption. Nothing in this article is medical advice, and no statement here is intended to diagnose, treat, cure or prevent any condition. Study findings are reported as published and should not be read as evidence of effects in people.*